Antitumor Effect of Extracts from Compound Fomes fomentarius in vivo
HE Xiao-yi,GE Wei-hong,LIU Qiong,SHEN Xian-rong,HE Ying,JIANG Ding-wen,CHEN Wei,MO Lin-fang,LIU Yu-ming,HOU Deng-yong,WANG Qing-rong,QIAN Tian-tian
DOI: https://doi.org/10.11653/syfj2013150170
2013-01-01
Abstract:Objective: To investigate the anti-tumor activity in vivo of extract from compound Fomes fomentarius(ECF),and reveal the anti-tumor mechanism of ECF.Method: S180-bearing and Lewis tumorbearing mice models were established.Mice were divided into five groups,model group,cyclophosphamide(CTX) group,high-(0.15 g.kg-1),middle-(0.1 g.kg-1) and low-dose(0.05 g.kg-1) of ECF.The S180-bearing and Lewis tumor-bearing mice in every group received corresponding drugs for 10 and 15 days respectively,then the effects of ECF on tumor growth,thymus and spleen indexs,tumor necrosis factor(TNF-α) and macrophage colony-stimulating factor(M-CSF) levels were determined.Result: The inhibition rate of the three groups(low-,middle-,and high-dose group) of ECF in S180-bearing mice was 11.8%,47.1% and 58.8% respectively,and in Lewis tumor-bearing mice,the inhibition rate was 7.1%,57.1% and 28.6% respectively.Compared with model group,high-dose group of ECF could inhibit tumor growth and reduce M-CSF levels of S180-bearing mice(P <0.05),middle-dose group could inhibit tumor growth and reduce M-CSF levels of Lewis tumor-bearing mice(P < 0.05),high-dose group could increase thymus indexes,high-,middle-and low-dose groups of ECF could elevate TNF-α levels(P < 0.05,P < 0.01).Conclusion: ECF could exhibit effect on the growth of transplanted S180 and Lewis tumor,probably via increasing indexes of immune organ and the regulation of TNF-α and M-CSF expression.